patents
CellaVision acquires exclusive rights to novel microscopy technology
By AWA | Posted on April 8, 2021
AWA’s client CellaVision has signed an agreement to acquire the exclusive rights to a patent portfolio on Fourier Ptychographic Microscopy, a novel microscopy technology from Clearbridge BioPhotonics. CellaVision is an innovative, global medical technology company that develops and sells leading systems for routine analysis of blood and other body fluids in health care services. AWA...
EPO releases Patent Index 2020: Applications stable despite pandemic, healthcare innovation soars and the US tops geographic origin of applications outside of Europe
By AWA | Posted on March 18, 2021
The European Patent Office (EPO) released its Patent Index 2020 this week. Despite the coronavirus pandemic, filings remained stable with increases in applications from the medical technology, biotechnology and pharmaceutical industries. These increases helped to counter declines seen in some sectors like mechanical engineering. Top Industries As a result of the current global situation, it...
All eyes on Germany as UPC is resuscitated at Bundestag and Bundesrat
By Louise Jonshammar | Posted on December 18, 2020
German ratification of the UPCA is one of the last hurdles for the Unitary Patent system. The system has suffered a series of delays ever since an agreement was reached in 2012 that made the Unitary Patent possible through enhanced cooperation at an EU-level. The Unitary Patent system aims to provide easier and affordable access...
Tags: Bundesrat, EU, Europe, European patents, Germany, patents, unitary patent, UPC, UPCA
IP Strategy
By Anders Heebøll-Nielsen | Posted on December 17, 2020
In this fifth and final webinar in this series Anders Heebøll-Nielsen talks about the importance of creating an IP strategy, even for start-ups. Watch this webinar where we give you valuable input on how to get started with your own strategy. This webinar is in Danish.
China introduces compensation for patent terms
By AWA | Posted on December 15, 2020
On October 17, 2020, the Standing Committee of the 13th National People’s Congress passed amendments to the PRC Patent Law, which come into force June 1, 2021. The amendments cover three key areas: 1) Strengthening the protection of the legitimate rights and interests of patentees; 2) Promoting the implementation and application of patents; and 3)...
Tags: china, compensation, innovative drugs, patent terms, patents
Patents – What can be patented and how?
By Vibeke Warberg Rohde | Posted on December 7, 2020
Do you wish to know more about what can be patented and how it is done? Vibeke Warberg Rohde gives an introduction to the patent system and how to get started if you want to protect your invention with a patent.
Protecting Biological Drug Innovations
By AWA | Posted on November 11, 2020
Learn how to protect biological drug innovations during this webinar from Stockholm Science City (In Swedish). Ulrika Munter and Nora Spjuth share their experiences working with intellectual property in this field and Linus Plym Forshell from the Swedish Intellectual Property Office (PRV) provides an overview of IP strategies in the pharmaceutical sector. This webinar is in Swedish.
Tags: biological, drugs, innovations, patents, PRV
EU requires manufacturers to disclose scientific documents during risk assessment for food chain production
By Eric Van Malderen | Posted on September 30, 2020
The European Food Safety Agency (EFSA) is in charge of the registration into the European Union of novel foods and feeds, food and feed additives, food and feed contact materials, GMO’s, plant protection products, food and feed enzymes as well as food and feed flavourings. To increase the legitimacy and credibility of their opinions, food...
Tags: EFSA, EU, European Union, Food, Manufacturing, patents, trade secrets
Patenting Antibody and Cell Therapies – What to Do and What Not to Do
By Joanna Applequist, Louise Jonshammar, Niklas Mattsson | Posted on September 28, 2020
Antibody drugs and cell therapies are at the heart of new biotechnology science. Not only do they show great promise when it comes to curing disease and helping patients, but also in creating value and growth. Biotech companies need to protect their scientific results and the corresponding investments with strong and durable patents. This is...
Tags: antibodies, Biotechnology, cell therapies, EPO, Litigation, patents
Easing the Pain for SMEs – Effectiveness of External IP Counsel
By AWA | Posted on August 31, 2020
In this interactive webinar moderated by Cathrin Johansson, panellists Malin Wennberg and Anneli Jönsson take a closer look at some of the IP challenges facing SMEs and how utilising external IP counsel can help to ease the pain. They provide hands-on advice from experiences where AWA has acted as an in-house IP department or external...
Recent contributors
Partner, European Patent Attorney
Senior Associate, Attorney at Law
Partner, Attorney at Law, Group Vice President
Partner, Attorney at Law, Business Area Manager
Senior Counsel, European Patent Attorney
